The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis
- PMID: 29870555
- PMCID: PMC5988310
- DOI: 10.1371/journal.pone.0198602
The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis
Expression of concern in
-
Expression of Concern: The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.PLoS One. 2023 Apr 24;18(4):e0284938. doi: 10.1371/journal.pone.0284938. eCollection 2023. PLoS One. 2023. PMID: 37093816 Free PMC article. No abstract available.
Abstract
Introduction: Bladder cancer (BC) is one of the most common urologic malignancies and it is urgently needed to identify novel potential prognostic biomarkers for predicting prognosis and progression of patients with BC in clinical practice. Previous research has revealed that long noncoding RNAs (lncRNAs) played critical roles in BC, and may serve as novel potential prognostic biomarkers in patients with BC. Therefore, we conducted this meta-analysis to clarify the prognostic potential of lncRNAs in BC patients.
Methods: A comprehensive search was performed in PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI). According to the predefined exclusion and inclusion criteria, a total of 9 recently published articles comprising 13 lncRNAs and 666 BC patients were included into this meta-analysis. We analyzed the hazard ratios (HRs) and 95% confidence intervals (CIs) to determine the relationship between lncRNAs expression and survival outcomes. We also analyzed the odds ratio (ORs) and 95% confidence intervals (CIs) to assess the association between lncRNAs expression and clinicopathological characteristics, including histological grade, gender, multifocality, tumor size, and tumor stage.
Results: Our results revealed that high lncRNAs expression was associated with shorter overall survival in Asian BC patients (pooled HR = 2.32, 95% CI: 1.35-4.00, P = 0.002, random-effect). High lncRNAs expression levels were significantly associated with histological grade (G2-G3 vs. G1: OR = 3.857, 95%CI: 1.293-11.502, P = 0.015, random-effect).
Conclusions: In summary, this meta-analysis has demonstrated that lncRNAs could be used as potential prognostic markers for BC and high lncRNAs expression could predict poor prognosis among Asian BC patients.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





References
-
- GLOBOCAN. Cancer incidence, mortality and prevalence worldwide in 2012 Lyon, France: International Agency Research on Cancer, 2012. Available from: http://globocan.iarc.fr
-
- Babjuk M, Burger M, Zigeuner R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle invasive urothelial carcinoma of the 2011 update. Eur Urol 2013;64:639–653. doi: 10.1016/j.eururo.2013.06.003 - DOI - PubMed
-
- Van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009;56:430–442. doi: 10.1016/j.eururo.2009.06.028 - DOI - PubMed
-
- Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, et al. Predictivevalue of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer. 2010;9:3 doi: 10.1186/1476-4598-9-3 - DOI - PMC - PubMed
-
- Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al.Long non-coding RNA HOTAIR regulates Polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71:6320–6. doi: 10.1158/0008-5472.CAN-11-1021 - DOI - PubMed